Metastatic prostate cancer participation study
Part of Cancer, Kidney & urinary clinical trials.
This study looks at patterns of participation among people with metastatic prostate cancer. It aims to understand how patients engage with their care and research, which could help improve future trial designs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with prostate cancer that has spread to other parts of the body
- You are able to understand and sign a consent form
- You are not currently enrolled in another research study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks men with prostate cancer about their experience preparing for and joining clinical trials. It may help improve how future trials are explained and supported for patients.
This study looks at how social, lifestyle, and other factors affect prostate cancer outcomes. It enrolls men who have chosen to have their prostate removed (radical prostatectomy) and agreed to join a biobank.
This study looks at how people with endometrial cancer manage their care and treatment. It aims to understand your experiences to help improve support for others.
This study asks people with metastatic prostate cancer and their doctors about what benefits and risks matter most when choosing treatment. Your answers can help improve how treatment options are discussed in Hong Kong.
This study collects health information from patients with cancer that has spread to the liver. Researchers will track your medical history and outcomes to better understand how metastatic liver cancer develops and progresses.
This study follows men with advanced prostate cancer that has spread to other parts of the body. It aims to learn more about how the disease and treatments affect patients over time, so doctors can improve care.
Hear when a new Metastatic Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.